Notícias e Atividades da Relmada Therapeutics

Relmada Therapeutics é uma empresa listada sob o símbolo RLMD (US).

Veja o organograma con seus 18 executivos principais

Biografias mais buscadas da Relmada Therapeutics

• Sergio Traversa, Chief Executive Officer and Director
• Charles Casamento, Chairman of the Board
• Fabiana Fedeli, Director

Recentes movimentos de executivos em Relmada Therapeutics

• Michelle Noel, ingressou na Companhia como Director of Data Management  (Notícia publicada em 22 de dezembro de 2025).

Criar um alerta
para seguir os movimentos de executivos da Relmada Therapeutics.

Relmada Therapeutics possui 2.405 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e BioNTech (Alemanha).

Popular M&A news in Biotecnologia

• IMU Biosciences acaba de anunciar uma arrecadação de fundos de 53 milhões de dólares. (publicado em 3 de junho de 2026).
• NewLimit acaba de anunciar uma arrecadação de fundos de 435 milhões de dólares. (publicado em 3 de junho de 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (publicado em 1 de junho de 2026)..

Outros contatos sugeridos na indústria do Biotecnologia

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer da Inceptive
• Jan Van de Winkel - President and Chief Executive Officer da Genmab
• Valerie Hanote - Non-Executive Director da Eurofins

Saiba mais sobre a indústria do Biotecnologia

Últimos comunicados de imprensa de Relmada Therapeutics

• Relmada Therapeutics Announces Participation in the 2021 SVB Leerink Global Healthcare Conference :: Relmada Therapeutics, Inc. (RLMD)
• Relmada Therapeutics Announces Initiation of Phase 3 Program for REL-1017 as Adjunctive Treatment for Patients with Major Depressive Disorder :: Relmada Therapeutics, Inc. (RLMD)
• Relmada Therapeutics to Participate in Upcoming Investor Conferences :: Relmada Therapeutics, Inc. (RLMD)
• Press releases :: Relmada Therapeutics, Inc. (RLMD)
• Relmada Therapeutics Expands R&D Team, Appoints Paolo Manfredi, M.D., as Acting Chief Scientific Officer, Marco Pappagallo, M.D., as Acting Chief Medical Officer and Updates R&D Milestones :: Relmada Therapeutics, Inc. (RLMD)
• Press releases :: Relmada Therapeutics, Inc. (RLMD)
• Email alerts :: Relmada Therapeutics, Inc. (RLMD)
• IR calendar :: Relmada Therapeutics, Inc. (RLMD)
• Relmada Therapeutics Announces Uplisting to the Nasdaq Global Select Market® :: Relmada Therapeutics, Inc. (RLMD)
• Relmada Therapeutics Announces Notice of Allowance for Patent in Canada Covering REL-1017 for Treatment of Psychiatric Symptoms :: Relmada Therapeutics, Inc. (RLMD)
• View more press releases Close

Redes sociais sobre Relmada Therapeutics

• Relmada Therapeutics na Wikipedia, Google News e Yahoo Finance
• Relmada Therapeutics na LinkedIn, X (Twitter) e YouTube